(1-Butyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)boronic acid

Catalog No. :
ACRZSG925
CAS No. :
2377611-39-5
Molecular Formula :
C8H12BF3N2O2
Molecular Weight :
236.00

IUPAC Name:(1-butyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)boronic acid

(1-Butyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$176.00Login to see priceInquiryInquiry
5g98%$488.00Login to see priceInquiryInquiry
10g98%$839.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-Butyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)boronic acid
IUPAC Name(1-butyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)boronic acid
MDL No.MFCD24448771
Molecular FormulaC8H12BF3N2O2
Molecular Weight236.00
SMILESOB(O)C1=CC(C(F)(F)F)=NN1CCCC
InChI KeyQWFNIPKLRPHQLC-UHFFFAOYSA-N
Synonym1-Butyl-3-(trifluoromethyl)pyrazole-5-boronic acid;Boronic acid, B-[1-butyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]-
CAS No.2377611-39-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRZSG925 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVGZE082 route compound structure diagram
    ACVGZE0821346270-08-3 In Stock
  4. Then
  5. ACRZSG925 route product structure diagram
    ACRZSG9252377611-39-5
Inquiry

2. ACRZSG925 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWNBC185 route compound structure diagram
    ACWNBC18570629-61-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRZSG925 route product structure diagram
    ACRZSG9252377611-39-5
Inquiry

Comments (0)